FDA Approves Obagi saypha MagIQ: A New Era in Dermal Fillers
Obagi saypha MagIQ, the newly FDA-approved hyaluronic acid (HA) gel filler, is set to become a significant addition to the U.S. aesthetic market and will be available starting in 2026. The filler headlines Obagi Medical’s expansion into injectable products, offering a novel approach to dermal fillers for patients seeking natural-looking results and safety proven across [...]